Ascendis Pharma A/SASNDNASDAQ
Loading
Gross Profit Over TimeExpanding
Percentile Rank100
3Y CAGR+151.3%
5Y CAGR+145.4%
Year-over-Year Change
Revenue minus cost of goods sold
3Y CAGR
+151.3%/yr
vs +38.6%/yr prior
5Y CAGR
+145.4%/yr
Recent acceleration
Acceleration
+112.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
89.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $619.30M | +93.9% |
| 2024 | $319.38M | +43.7% |
| 2023 | $222.32M | +469.5% |
| 2022 | $39.04M | +817.4% |
| 2021 | $4.25M | -38.8% |
| 2020 | $6.95M | -48.0% |
| 2019 | $13.38M | +26.4% |
| 2018 | $10.58M | +591.6% |
| 2017 | $1.53M | -66.8% |
| 2016 | $4.61M | - |